Enjoy!!!
OK, without further ado....
[size=+3]The ONE™[/size] by
Name: 17a-methyl-etioallocholan-17b-ol-3-hydroxyimine
Standard: Methyltestosterone
Androgenic: 140
Anabolic: 380
Estrogenic Activity: none
Progestational Activity: none
Brief History:
• Primary active ingredient (17a-methyl-etioallocholan-17b-ol-3-hydroxyimine) was first described by Z. Cekan and B. Pelc, Effects of 1-alkyl substitution on the biological action in a series of androstanes. Steroids 8,209 (1966).
• Never commercially produced – A COMPLETELY NOVEL MOLECULE.
Product Characteristics:
• The One can inhibit the action of estrogens by acting as a competitive antagonist and/or decreasing the mRNA-induced transcription of estrogenic effects post-binding.
• The One can also act like an aromatase inhibitor, disallowing the conversion of androgens to estrogen.
• The One activates GLUT-4 receptors in skeletal muscle, and also increases glycogen uptake. The One is 17-alpha alkylated greater oral bioavailability.
• The One can significantly lower SHBG levels, allowing for more active product to reach skeletal muscle.
Effects Related to Physique Enhancement:
• Rapid lean body mass gains - typical users report 0.75 lb./day gains for first 2-3 weeks
• Overall hardening effect to physique
• Increased vascularity
• Increased strength
• Dramatically enhanced neural function (coordination) as DHT is the predominant androgen in neural function
• Mood-enhancing effect
• Lipolytic effect (increases fat metabolism)
ADMINISTRATION/DOSAGE:
• Effective dose: 67.5 - 90 mg/day (3-4 capsules) ; DO NOT EXCEED 90 MG/DAY
• Can be taken with or without food; preferably in the AM
• Oral Administration Only
• 4-5 week administration period; do not exceed 5 weeks duration
OK, without further ado....
[size=+3]The ONE™[/size] by
Name: 17a-methyl-etioallocholan-17b-ol-3-hydroxyimine
Standard: Methyltestosterone
Androgenic: 140
Anabolic: 380
Estrogenic Activity: none
Progestational Activity: none
Brief History:
• Primary active ingredient (17a-methyl-etioallocholan-17b-ol-3-hydroxyimine) was first described by Z. Cekan and B. Pelc, Effects of 1-alkyl substitution on the biological action in a series of androstanes. Steroids 8,209 (1966).
• Never commercially produced – A COMPLETELY NOVEL MOLECULE.
Product Characteristics:
• The One can inhibit the action of estrogens by acting as a competitive antagonist and/or decreasing the mRNA-induced transcription of estrogenic effects post-binding.
• The One can also act like an aromatase inhibitor, disallowing the conversion of androgens to estrogen.
• The One activates GLUT-4 receptors in skeletal muscle, and also increases glycogen uptake. The One is 17-alpha alkylated greater oral bioavailability.
• The One can significantly lower SHBG levels, allowing for more active product to reach skeletal muscle.
Effects Related to Physique Enhancement:
• Rapid lean body mass gains - typical users report 0.75 lb./day gains for first 2-3 weeks
• Overall hardening effect to physique
• Increased vascularity
• Increased strength
• Dramatically enhanced neural function (coordination) as DHT is the predominant androgen in neural function
• Mood-enhancing effect
• Lipolytic effect (increases fat metabolism)
ADMINISTRATION/DOSAGE:
• Effective dose: 67.5 - 90 mg/day (3-4 capsules) ; DO NOT EXCEED 90 MG/DAY
• Can be taken with or without food; preferably in the AM
• Oral Administration Only
• 4-5 week administration period; do not exceed 5 weeks duration